Aquestive Therapeutics, Inc. (AQST)
USD 3.0
(0.0%)
USD 3.0
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 91.07 Million USD | 146.24% |
| 2022 | 36.98 Million USD | -30.86% |
| 2021 | 53.49 Million USD | 43.91% |
| 2020 | 37.17 Million USD | -38.39% |
| 2019 | 60.33 Million USD | 41.63% |
| 2018 | 42.6 Million USD | -6.38% |
| 2017 | 45.5 Million USD | 17.74% |
| 2016 | 38.65 Million USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 108.5 Million USD | 19.14% |
| 2024 Q2 | 110.16 Million USD | -72.35% |
| 2024 Q3 | 36.36 Million USD | 4.16% |
| 2023 Q3 | 40.06 Million USD | 51.69% |
| 2023 Q4 | 91.07 Million USD | 127.33% |
| 2023 FY | 91.07 Million USD | 146.24% |
| 2023 Q1 | 30.9 Million USD | -16.45% |
| 2023 Q2 | 26.41 Million USD | -14.53% |
| 2022 Q4 | 36.98 Million USD | -7.57% |
| 2022 Q3 | 40.01 Million USD | -11.71% |
| 2022 Q2 | 45.32 Million USD | -8.23% |
| 2022 FY | 36.98 Million USD | -30.86% |
| 2022 Q1 | 49.39 Million USD | -7.68% |
| 2021 Q4 | 53.49 Million USD | 53.47% |
| 2021 Q2 | 36.48 Million USD | -0.93% |
| 2021 Q3 | 34.85 Million USD | -4.46% |
| 2021 FY | 53.49 Million USD | 43.91% |
| 2021 Q1 | 36.82 Million USD | -0.93% |
| 2020 Q1 | 64.34 Million USD | 6.64% |
| 2020 FY | 37.17 Million USD | -38.39% |
| 2020 Q4 | 37.17 Million USD | -41.36% |
| 2020 Q3 | 63.39 Million USD | -2.09% |
| 2020 Q2 | 64.74 Million USD | 0.62% |
| 2019 Q4 | 60.33 Million USD | 0.94% |
| 2019 Q3 | 59.77 Million USD | 27.5% |
| 2019 Q2 | 46.88 Million USD | 15.08% |
| 2019 Q1 | 40.74 Million USD | -4.37% |
| 2019 FY | 60.33 Million USD | 41.63% |
| 2018 Q1 | 44.31 Million USD | -2.62% |
| 2018 FY | 42.6 Million USD | -6.38% |
| 2018 Q3 | 44.05 Million USD | -2.81% |
| 2018 Q4 | 42.6 Million USD | -3.29% |
| 2018 Q2 | 45.33 Million USD | 2.29% |
| 2017 FY | 45.5 Million USD | 17.74% |
| 2017 Q1 | - USD | 0.0% |
| 2017 Q4 | 45.5 Million USD | 0.0% |
| 2016 FY | 38.65 Million USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Esperion Therapeutics, Inc. | 501.54 Million USD | 81.841% |
| Theratechnologies Inc. | 51.26 Million USD | -77.671% |
| Safety Shot Inc | 304.9 Thousand USD | -29770.092% |
| Cosmos Health Inc. | 3.03 Million USD | -2900.52% |
| Cronos Group Inc. | 1.55 Million USD | -5741.95% |
| Ironwood Pharmaceuticals, Inc. | 498.3 Million USD | 81.723% |
| Kala Pharmaceuticals, Inc. | 34.19 Million USD | -166.382% |
| Organogenesis Holdings Inc. | 60.74 Million USD | -49.932% |
| Universe Pharmaceuticals INC | - USD | -Infinity% |
| ProPhase Labs, Inc. | 10.25 Million USD | -787.853% |
| Sonoma Pharmaceuticals, Inc. | 87 Thousand USD | -104585.057% |
| Dynavax Technologies Corporation | 252.41 Million USD | 63.919% |
| Radius Health, Inc. | 339.66 Million USD | 73.187% |
| China SXT Pharmaceuticals, Inc. | 117.12 Thousand USD | -77657.003% |
| Alvotech | 1.02 Billion USD | 91.138% |
| Sunshine Biopharma, Inc. | 539.03 Thousand USD | -16796.12% |
| Alpha Teknova, Inc. | 13.25 Million USD | -587.314% |
| Intra-Cellular Therapies, Inc. | 13.32 Million USD | -583.446% |
| SCYNEXIS, Inc. | 12.15 Million USD | -649.042% |
| Harrow Health, Inc. | 183.17 Million USD | 50.278% |
| Biofrontera Inc. | 804 Thousand USD | -11227.861% |
| DURECT Corporation | 2.7 Million USD | -3270.688% |
| Supernus Pharmaceuticals, Inc. | 33.19 Million USD | -174.358% |
| ANI Pharmaceuticals, Inc. | 309.66 Million USD | 70.589% |
| OptiNose, Inc. | 611 Thousand USD | -14806.056% |
| RedHill Biopharma Ltd. | 455 Thousand USD | -19916.703% |
| Cumberland Pharmaceuticals Inc. | 12.78 Million USD | -612.414% |
| SIGA Technologies, Inc. | 335.99 Thousand USD | -27006.678% |
| Lifecore Biomedical, Inc. | 120.51 Million USD | 24.425% |
| Shineco, Inc. | 10.01 Million USD | -809.184% |
| Phibro Animal Health Corporation | 458.28 Million USD | 80.127% |
| Procaps Group S.A. | 28.41 Million USD | -220.577% |
| TherapeuticsMD, Inc. | 6.53 Million USD | -1294.305% |
| Regencell Bioscience Holdings Limited | - USD | -Infinity% |
| Viatris Inc. | 16.18 Billion USD | 99.437% |
| Sunshine Biopharma, Inc. | 539.03 Thousand USD | -16796.12% |
| Rockwell Medical, Inc. | 8.29 Million USD | -998.228% |
| Incannex Healthcare Limited | 210 Thousand USD | -43269.524% |
| Aytu BioPharma, Inc. | 10.87 Million USD | -737.326% |
| Tilray Brands, Inc. | 287.93 Million USD | 68.369% |
| Collegium Pharmaceutical, Inc. | 489.96 Million USD | 81.412% |
| PetIQ, Inc. | 437.82 Million USD | 79.198% |
| Silver Spike Investment Corp. | - USD | -Infinity% |
| Neurocrine Biosciences, Inc. | 258.3 Million USD | 64.74% |
| Journey Medical Corporation | 14.62 Million USD | -522.87% |
| Alimera Sciences, Inc. | 64.48 Million USD | -41.227% |
| Petros Pharmaceuticals, Inc. | 6.85 Million USD | -1228.149% |
| Assertio Holdings, Inc. | 38.51 Million USD | -136.475% |
| Shuttle Pharmaceuticals Holdings, Inc. | 135.08 Thousand USD | -67319.257% |
| Embecta Corp. | 1.62 Billion USD | 94.397% |
| Cyclo Therapeutics, Inc. | 22.48 Thousand USD | -404970.272% |
| Procaps Group, S.A. | 28.41 Million USD | -220.577% |
| PainReform Ltd. | 30 Thousand USD | -303486.667% |
| Avadel Pharmaceuticals plc | 32.75 Million USD | -178.01% |
| Hempacco Co., Inc. | 5.93 Million USD | -1435.592% |
| Talphera, Inc. | - USD | -Infinity% |
| Pacira BioSciences, Inc. | 513.79 Million USD | 82.274% |
| Alvotech | 1.02 Billion USD | 91.138% |
| Lantheus Holdings, Inc. | 616.12 Million USD | 85.218% |
| Kamada Ltd. | 7.43 Million USD | -1124.469% |
| Indivior PLC | 235.66 Million USD | 61.354% |
| Currenc Group, Inc. | 2.5 Million USD | -3532.906% |
| Evoke Pharma, Inc. | 5 Million USD | -1721.52% |
| Flora Growth Corp. | 942 Thousand USD | -9568.365% |
| Cyclo Therapeutics, Inc. | 22.48 Thousand USD | -404970.272% |
| Evolus, Inc. | 120.35 Million USD | 24.33% |
| HUTCHMED (China) Limited | 48.18 Million USD | -88.997% |
| Amphastar Pharmaceuticals, Inc. | 589.19 Million USD | 84.542% |
| Akanda Corp. | 2.49 Million USD | -3547.191% |